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Objective: Cranioplasty is indicated to restore form and function of bone defects of the neurocranium.
Autografts are the gold standard, alloplastic materials are used when autologous bone is unavailable or
unsuitable, and increasing evidence supports the use of patient-specific implants (PSIs) for reconstruc-
tion. We reviewed our own patient data to assess pre- and intraoperative aspects, complications and
costs in patients that were treated with PSIs from titanium or polyetheretherketone (PEEK) for skull bone
reconstruction.
Methods: We retrospectively evaluated all patients receiving a PSI as at least a secondary reconstruction
between 2004 and 2016 at Maastricht University Medical Center. These cases were analyzed for
demographics, perioperative surgical and medical aspects, as well as costs.
Results: In total 30 patients received PSIs, of which 20 were included in this study. Duration of PSI
placement was not statistically different between group I, where previously placed reconstruction
material was still in situ, and group II, where no remaining previously placed reconstruction material was
present (group I: 104 ± 27 mins, group II: 86 ± 36 mins; p ¼ 0.27). Postoperatively, 2 patients experi-
enced complications (10%). Costs of obtaining the PSIs were not significantly different between group I
and group II (group I: mean EUR 7536 ± 2759, group II: mean EUR 8351 ± 2087, p ¼ 0.51).
Conclusion: Treatment of skull bone defects in repeated reconstruction requires an optimal preoperative
planning and intraoperative procedure. In this retrospective study comparing repeatedly reconstructed
cases with and without remaining previously placed reconstruction material present at the surgical site,
we could not find significant differences in the duration of the surgical procedure nor costs of obtaining
the PSIs. The protocol followed at MUMC for preoperative planning, manufacturing, and surgery,
represents the current state-of-the-art treatment.
© 2019 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights
reserved.illofacial Surgery, Maastricht
Maastricht, the Netherlands.
axillo-Facial Surgery. Published by1. Introduction
Cranioplasty, the repair of neurocranial defects, remains a
challenging procedure in reconstructive craniofacial surgery. De-
fects of the neurocranium can occur for many reasons, e.g. after
decompression surgery for stroke, craniectomy for intracerebral
infections or trauma, oncological resections, or craniectomy for
epilepsy or aneurysm surgery. The reconstruction of neurocranial
defects is important to restore both form (symmetry) and functionElsevier Ltd. All rights reserved.
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life), and always involves surgery (Zegers et al., 2017). Neurocranial
defects can be of considerable size (i.e. over 100 cm2) and are dis-
figuring. The size, anatomical location and extent of the defect, and
involvement of the orbital rim, e.g., are directly related to the
possibilities but also to the difficulties of this delicate surgery
(Poukens et al., 2008).
The use of autologous bone is still regarded as the gold standard
in reconstruction of any kind of bone defect. The autologous bone
graft, harvested during a craniectomy procedure, e.g., can be
replaced, or new bone can be harvested from a donor site in the
same patient, if the original material is absent or unsuitable for
other reasons. The latter is time-consuming, adds donor site
morbidity, and is impossible in cases in which no donor site is
suitable to provide an adequate amount of bone to restore the
defect (Lethaus et al., 2011). Additionally, there is a risk of resorp-
tion of the grafted bone. Using autologous bone for cranioplasty is
associated with a failure rate of up to 30% (Kimchi et al., 2016; Hng
et al., 2015). Alternatively, alloplastic materials can be used for
reconstruction. Alloplastic materials can either be used in a stan-
dardized off-the-shelf form, subsequently made to fit during sur-
gery, or preoperatively customized to fit the patient's defect on a
truly individualized basis. Frequently used alloplastic materials
include metals such as titanium (Ti), acrylics such as poly-
methylmethacrylate (PMMA), ceramics (hydroxyapatite [HA]), or
polymers such as polyetheretherketone (PEEK) (Zanotti et al.,
2016). Over the last decade, patient-specific implants (PSIs),
designed and manufactured using computer-aided design/com-
puter-aided manufacturing (CAD-CAM) technology, became avail-
able for primary, secondary and subsequent cranioplasty. Based on
a CT scan of the patient, an implant is virtually designed using CAD
software, and manufactured through either subtraction methods
(high-speed milling) or additive manufacturing techniques
(Lethaus et al., 2011, 2014; Park et al., 2016).
It is important to notice that the neurological status or recovery
of a patient is leading in the planning of reconstructive procedures
related to the neurocranium. The surgical difficulties result from
various factors. In most cases, the time between craniectomy and
reconstruction is difficult to estimate, as the recovery and reha-
bilitation of a patient can take months or years. However, if
autologous bone is stored for a long time, the chances of reinte-
gration and revitalization of these specimen diminish, leading to
resorption instead of remodeling (Brommeland et al., 2015). It is not
unusual that still today patients with multiple attempts of neuro-
cranial reconstructions present to specialized units such ours at
Maastricht University Medical Center (MUMC).
This study refers exclusively to patients with repeatedly
reconstructed neurocranial defects. We present data related to
planning, duration of surgical procedure, complication rate, and
costs. All patients received PSIs made from titanium or PEEK.
2. Materials and methods
2.1. Selection of patients and data acquisition
The medical records of all patients who underwent cranioplasty
with a PSI at the Department of Cranio-Maxillofacial Surgery of
MUMC between 2004 and 2016 were reviewed. Patients that
received a PSI as at least a secondary reconstruction were included
in this study. Patients without previous reconstruction and cases
with insufficient data were excluded. Data for both titanium and
PEEK reconstructions were pooled for analyses, and no comparison
between titanium and PEEK was made.
From the medical records of the included patients, the following
information was extracted: sex, age at PSI placement, diagnosisleading to craniectomy, type and timing of previous non-PSI re-
construction(s), diagnosis leading to failure of non-PSI re-
construction(s), defect size classification, presence or absence of
previously placed reconstruction material at the time of PSI
placement, PSI material and manufacturer, duration of the surgical
procedure of PSI placement, postoperative complications, and costs
of obtaining the PSIs.
All information was available either through digitalized paper
charts or electronicmedical records (SAP GmbH,Walldorf, Germany).
2.2. Defect classification
The defects were classified according to earlier reports in the
literature. This classification includes the size of the defect, orbital
involvement and whether the sagittal midline of the skull is
crossed. It ranges from class I to VI with increasing difficulty in
design and manufacturing of PSIs (Poukens et al., 2008).
2.3. Variables
The duration of the surgical procedure of PSI placement was
compared between the group of patients who still had remaining
cranioplasty material (or remnants thereof) in situ (group I) with
the group who did not have remaining cranioplasty material in situ
(group II). Other variables were the postoperative complication rate
and the costs of obtaining the PSIs.
2.4. Statistical analysis
Statistical analysis was performed using SPSS 24 (IBM Corp.,
Armonk NY, USA). A KolmogoroveSmirnov test was used to assess
all continuous variables for normality, given the small sample sizes.
A two-sided independent t-test was used to analyze differences in
the operation time, and a one-sided independent t-test was used to
analyze the hypothesized decrease in cost of PSIs. Statistical sig-
nificance was set at p  0.05.
2.5. Ethical approval
This study was approved by our local medical ethical committee
(METC 17-04-039).
3. Results
Between 2004 and 2016, a total of 30 patients underwent cra-
nioplasty with a PSI at MUMC. Of these patients, 20 patients had
received an earlier non-PSI reconstruction of the neurocranial
defect and were included in this study. Eight patients had not
previously undergone reconstruction and were excluded from this
study. Two additional patients were excluded because of insuffi-
cient data. According to the defect size classification of Poukens
et al., 10 patients had a class II, 9 patients a class III, and 1 patient a
class IV skull bone defect (Poukens et al., 2008). A flowchart of
inclusion and exclusion of cases is presented in Fig. 1.
The diagnoses leading to craniectomywere tumor (n¼ 7), trauma
(n¼ 5), epilepsy or aneurysm (n¼ 3), stroke (n¼ 3), and intracranial
infection (n¼ 2). Of the 20 patients who had received an earlier non-
PSI reconstruction, 10 patients received a cranioplasty during the
initial craniectomy procedure. In 7 patients, the autologous bone
graft was replaced. Two patients received a PMMA reconstruction,
and 1 patient underwent reconstruction with a titanium mesh. A
cranioplasty at a later stage was performed in the other 10 patients.
Nine patients underwent replacement of the autologous bone graft.
One patient underwent reconstruction using autologous rib grafts. A
summary of the patient data is presented in Table 1.
Table 1
Patient data.
Patient data, n ¼ 20
Sex, n (%)
Male 15 (75)
Female 5 (25)
Age at PSI placement, mean (SD) 42 (±17)
Diagnosis leading to craniectomy, n (%)
Tumor 7 (35)
Trauma 5 (25)
Epilepsy or aneurysm 3 (15)
Stroke 3 (15)
Intracranial infection 2 (10)
Defect class, n (%)
II 10 (50)
III 9 (45)
IV 1 (5)
Previous reconstruction, n (%)
Replacement of autologous bone graft 16 (80)
PMMA 2 (10)
Titanium mesh 1 (5)
Autologous bone transplant 1 (5)
Indication for PSI reconstruction, n (%)
Infection bone graft 11 (55)
Infection of alloplastic material 2 (10)
Resorption bone graft 4 (20)
Remaining defect, contour correction 1 (5)
Mechanical failure of non-PSI material 1 (5)
Other 1 (5)
PSI material, n (%)
Titanium 5 (25)
PEEK 15 (75)
Total PSI placements 
(n=30)
Previous reconstruction 
performed (n=20)
(included)
No previous reconstruction 
performed (n=8)
(excluded)
Insufficient data (n=2)
(excluded)
Reconstruction material in 
situ during PSI placement 
(n=7)
No reconstruction material 
in situ during PSI 
placement (n=13)
Fig. 1. Flowchart of in- and exclusion of cases.
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cranioplasty was removed entirely in a separate procedure before
reconstruction with a PSI. The indication for removal was infection
in all 13 cases. The duration of the surgical procedure to remove the
previously placed cranioplasty material was retrievable in 7 cases,
and was a mean of 67 ± 43 min (Table 2). In 7 of 20 patients (35%),
the previously placed cranioplasty material or remnants thereof
were still present at the time of PSI placement. Indications for
reconstruction with a PSI were as follows: bone resorption in 4
patients (Fig. 2), 1 patient had a remaining defect and required
contour correction, 1 patient experienced a mechanical failure of
the non-PSI material (Fig. 3), and 1 patient was reconstructed with
a PSI for other reasons. The indications for reconstruction are
summarized in Table 1.
All patients underwent operation by a team of senior surgical
staff members, consisting of a craniofacial surgeon and plastic
surgeon, or craniofacial surgeon and neurosurgeon.
Five patients underwent reconstruction with titanium PSIs, and
15 patients with PEEK PSIs (Fig. 4). The PSIs were designed andmanufactured by the engineering department of MUMC (IDEE,
Maastricht, the Netherlands), by Xilloc (Geleen, the Netherlands),
or KLS Martin (Tuttlingen, Germany). In all cases, the same design
protocol was followed. A recent and accurate CT scan of the head of
the patient was obtained, not older than 6 months and with a slice
thickness 1 mm, and was delivered to the manufacturing com-
pany. After approval of the CT scan quality and segmentation of the
CT scan data, an engineer designed the first draft of the PSI. In close
cooperation between the engineer and the ordering surgeon, all the
subsequent design steps were checked off by the ordering surgeon.
This included basic requirements such as outline/curvature/fixation
points and PSI material, but also the incorporation of design aspects
that could account for the presence of remaining cranioplasty
material from earlier reconstructive attempts. At least one instance
was noted of direct contact (face-to-face or videoconference) to
discuss the details of the case. As a requirement, the ordering
surgeon approved the final design in writing (Lethaus et al., 2011).
The implants were subsequently manufactured using either sub-
tractive or additive manufacturing techniques.
Records of the duration of the surgical procedure of PSI place-
ment in patients who had previously placed cranioplasty material
or remnants of it in situ were available in 7 of 7 cases (group I,
n ¼ 7). The mean duration was 104 ± 27 min. The duration of the
surgical procedure of PSI placement in patients with no remaining
cranioplasty material in situwas available in 11 of 13 cases (group II,
n ¼ 11), and was a mean of 86 ± 36 min. There was no statistically
significant difference between the duration of the surgical pro-
cedure in group I and group II (p ¼ 0.27) (Table 2).
Postoperative complications occurred in 2 of 20 cases (10%).
Both complications occurred in group II and both in patients
reconstructed with PEEK implants. One patient developed a sub-
cutaneous hematoma that resolved using repeated aspiration. One
patient developed a wound infection of the skin and subsequent
wound dehiscence that required removal of the PSI (Table 2).
Costs of obtaining PSIs from themanufacturer were available for
6 of 7 cases in group I and 10 of 13 cases in group II. Costs were not
significantly different between group I and group II (group I: mean
EUR 7536 ± 2759, group II: mean EUR 8351 ± 2087, p ¼ 0.51)
(Table 2).4. Discussion
In the last decade, experience with PSIs for cranioplasty of skull
bone defects has increased tremendously. This is also reflected by
an increasing number of publications. At MUMC. all patients with
large skull bone defects of more than 100 cm2 have been consis-
tently treated with PSIs since 2004. This retrospective analysis
Fig. 2. 3D rendering of CT-scans, showing a) the preoperative situation, resorption of bone graft in the right temporoparietal region, and b) the postoperative situation, PSI in situ.
Fig. 3. 3D rendering and segmentation of CT-scans from a case with a left-hand side temporoparietal bone defect. Image a) lateral, b) frontal, and c) cranial view of preoperative
situation, with fractured and displaced cranioplasty material in situ. Image d) lateral, e) frontal, and f) cranial view of postoperative situation, with PSI in situ showing an
anatomical fit.
Table 2
Results. Group I had remaining cranioplasty material in situ at the time of PSI placement, group II had no remainingmaterial in situ. Duration of removal of non-PSI cranioplasty
material in a separate procedure available and shown for 7/11 cases. Duration of PSI placement available and shown for 7/7 cases in group I, and 11/13 in group II. Costs available
and shown for 6/7 cases in group I, and 10/13 cases in group II. Mean and standard deviation for surgical duration presented in minutes, for costs presented in EUR. 1p > 0.05;
2p ¼ 0.51.
Results, n ¼ 20 Group I (n ¼ 7) Group II (n ¼ 13)
n (%) Mean (SD) n (%) Mean (SD)
Duration of removal non-PSI cranioplasty 67 (±43)
Duration of PSI placement1 104 (±27) 86 (±36)
Complications 2 (10)
Costs2 7536 (±2759) 8351 (±2087)
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Fig. 4. Clinical images after placement and before skin closure, showing a) a PEEK, and b) a titanium PSI.
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to correct the neurocranial defect had not led to success earlier, and
in whom residual material, due to bone resorption or failure of
previously placed reconstruction material, was often still present at
the surgical site.
The irregular surfaces of thewound bed presented no significant
challenges for the CAD planning and implant placement. It can be
assumed that, because therewas no difference between group I and
group II concerning operation time, the implant fit was equal in
both groups. Also, clinically all implants fitted well without the
need for intraoperative corrections to the PSI in both groups, as
assessed by the lead surgeon. This might be attributed to accurate
preoperative planning, whereby the dimensions of the remaining
reconstruction material were assessed, allowing for incorporation
of design features that minimized the need for intraoperative
manipulation of the remaining reconstruction material. The shift of
time to the preoperative planning phase relieves pressure from one
of the most costly aspects of surgery: the actual operation time
(Shibahashi et al., 2017). The current treatment protocol for PSIs
used at MUMC has successfully been used for more than 10 years
(Lethaus et al., 2011). Other authors have reported success even
though intraoperative manipulation of PEEK implants was neces-
sary (O'Reilly et al., 2015).
Generally, preparation time for the soft tissues and wound bed
was greater in patients with residual hard tissues in the defect area.
Preparation of the scalp skin layers required great care and experi-
ence, because previous multiple operations and infections had
severely impaired the structure and quality of the soft tissue coverage.
The risk of inducing wound healing disturbances by re-entering the
operation site was increased. Pre-existing incisions/scars were always
used for preparation. However, due to the multiple interventions, the
tissues were scarred and no longer optimally perfused. Furthermore,
care was taken to avoid the formation of cerebral fistulas and cere-
brospinal fluid leakages. This is the main reason why residual hard
tissues in the defect area were often not removed.
The number of postoperative complications after PSI placement
in this study was 10%, which is considerably low and corresponds to
what is found in the literature. Both complications occurred in pa-
tients treated with PEEK PSIs, which is likely attributable to the
higher absolute number of patients treated with PEEK PSIs in our
patient group. Postoperative hemorrhage occurred in 1 patient, and
was treated by repeated aspiration, after which the wound healed
primarily. Wound infection and subsequent dehiscence of the skin in
the other patient, however, did require an extra surgical procedure to
remove the PSI. This case was different from all the others, because
the operation time was longer due to an additional neurosurgical
intervention in combination with PSI placement. Most importantly,
the incision line had to be placed across the defect area. As thewound closure had to be placed on the PEEK implant and not on the
patient's bone, it is not surprising that the wound breakdown
happened exactly over the PEEK implant. For future cases, it should
be stressed that the scalp incision should never be placed across the
defect and that the implant should always be securely covered by
intact skin. The prolonged operation time could have also played a
role in this event (Shibahashi et al., 2017). In accordance with the
patient, no further reconstructive attemptwill bemade, since several
infections had occurred before the PEEK PSI placement. In PEEK
implant case series, complication rates between 0% and 35% have
been reported, next to surgical removal rates ranging from 0% to
18.2% (Ng and Nawaz, 2014; Alonso-Rodriguez et al., 2015; Gerbino
et al., 2015; O'Reilly et al., 2015). No complications were seen in
patients receiving a titanium cranioplasty; however, it should be
noted that only a limited number of patients were treated with ti-
tanium PSIs. In the literature, complication rates of titanium PSIs are
reported varying from 4.1% to 29%, with surgical removal rates
ranging from 0% to 15.9% (Kung et al., 2012; Wiggins et al., 2013;
Williams et al., 2016).
Infection was the main reason for failure in previous recon-
structive attempts. Treating the infected non-PSI cases involved at
least one additional hospitalization and surgical procedure for
removal of the infected primary cranioplasty material, which poses
a burden not only to the patients and their social environment
emotionally and economically, but also to the medical infrastruc-
ture, possibly even more so in an acute setting. Increasing the
predictability of the first reconstructive procedure will contribute
to decreasing the number of surgeries needed, and will benefit
these high-risk patients, as more surgical interventions do not
necessarily lead to better results. More data prove that the gold
standard practice of replacing the original autologous bone graft
may be becoming obsolete and that use of alloplastic materials
could be advised as the primary means of repair (Lethaus et al.,
2014; Schwarz et al., 2015; Honeybul et al., 2017).
The initial diagnosis for craniectomy in all relevant studies
describing cranioplasty is diverse, as has been seen here. In nearly
all patients, the gold standard practice of using autologous bone
(i.e., replacing the original bone graft) was followed as a first
attempt to reconstruct the defect. Only in the cases where the
autologous bone graft was absent or unsuitable were other mate-
rials used. Not only technical aspects play a role in immediate or
delayed reconstruction: the neurological and general condition of
the patient may be impaired, and this may increase the complexity
of surgery or even lead to inoperability.
The ultimate goal of reconstruction is to improve the neuro-
logical function of the patient by restoring the integrity of the skull
(Poeck, 1987). A recent study by Zegers et al. showed an over-
whelming rate of patient satisfaction after skull bone
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improved quality of life, decreased pain and headache, while giving
aesthetically good results (Zegers et al., 2017). Interestingly, it was
often the patient's wish that led to the CAD planning and surgery
using PSIs, despite multiple previous operations and despite sub-
stantial risks. The study by Zegers et al. is the first ever to retro-
spectively assess patient satisfaction and quality of life after PSI
placement in neurocranial bone defects. According to this study,
patient satisfaction should be taken into account in the decision
making process of reconstructive options.
Costs have long been considered a major drawback of using PSIs
for cranioplasty. Generally authors have balanced the benefits of
PEEK PSIs positively against the high costs (Lethaus et al., 2014;
Jalbert et al., 2014; Alonso-Rodriguez et al., 2015; O'Reilly et al.,
2015). Other authors could not find statistically significant differ-
ences in overall costs between autologous bone graft and PEEK
cranioplasty or titanium cranioplasty (Gilardino et al., 2015;
Honeybul et al., 2017). Our study showed no significant difference
in costs for obtaining a PSI from the manufacturer between group I
and group II patients, potentially indicating that the preoperative
time that an engineer needs to plan andmanufacture the implant is
not substantially longer in cases in which the remaining recon-
struction material is still in situ. Over the course of time, the mean
price for obtaining a PSI will likely decrease. This is relevant in
everyday practice, where management of increasing health care
costs is of top priority. Routine production of PSIs for various in-
dications, a broad range of products and rapid advances in digital
design and manufacturing, and market forces, are likely to be the
main reasons for a cost reduction of these elaborate implants. In our
opinion, however, costs should ultimately not be a limiting factor in
treating patients who have undergone multiple unsuccessful re-
constructions, as these patients should be treated with the best
alternative solution.
The overall costs of treatment play an important role in medical
decision making today. The majority of patients in our study
received two or more surgeries that were ultimately unsuccessful,
although the gold standard treatment in reconstructive bone sur-
gery (i.e., the use of autogenous bone) had been followed. Repeated
surgery increased the overall costs andmedical risks for these high-
risk patients. Subsequently, reconstructing the patient with a PSI at
a later stage increased the overall costs and perioperative risks
further. Overall costs and perioperative risks can likely be
decreased when PSIs are used as the primary reconstructive solu-
tion, specifically in class III, IV, V and VI neurocranial defects.
Of course, PEEK is a material for current use. In the future, one
would want bioactive implants that are not only accepted by sur-
rounding tissues but are integrated as part of a living organism.
Limitations of the current study are the relatively small number
of cases in our cohort, and the retrospective study design, which
force us to interpret the presented results with caution. Further-
more, long-term results in PSI placement in neurocranial bone
defects are still missing.
5. Conclusion
Treatment of skull bone defects in repeated reconstruction re-
quires optimal preoperative planning and intraoperative execution.
In this retrospective study in patients with remaining cranioplasty
material in situ, we could not find significant differences in the
duration of the surgical procedure or costs of cranioplasty,
compared to those for patients without remaining material. The
protocol followed at MUMC for preoperative planning,
manufacturing, and surgery represents the current state-of-the-art
treatment. In future studies, we will focus on the biological activity
of cranioplasty materials to improve integration in the body.Conflicts of interest
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